Winthrop Partners - WNY, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 981 filers reported holding NOVARTIS A G in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Winthrop Partners - WNY, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2019$120,964,000
-4.8%
1,3920.0%0.08%
-13.7%
Q2 2019$127,103,000
-4.6%
1,3920.0%0.10%
-8.7%
Q1 2019$133,228,000
+25.8%
1,392
+12.8%
0.10%
+5.1%
Q4 2018$105,889,000
-0.4%
1,2340.0%0.10%
+15.1%
Q3 2018$106,321,000
+14.1%
1,2340.0%0.09%
+10.3%
Q2 2018$93,216,000
-6.8%
1,2340.0%0.08%
+1.3%
Q1 2018$100,040,0001,2340.08%
Other shareholders
NOVARTIS A G shareholders Q2 2018
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 332,962$27,452,0007.32%
Mawer Investment Management Ltd. 7,721,327$636,623,0005.86%
Martin Investment Management, LLC 133,246$10,986,0005.56%
SCHARF INVESTMENTS, LLC 1,330,175$109,673,0005.48%
Hansberger Growth Investors, LP 46,663$3,847,0005.19%
Bain Capital Public Equity Management II, LLC 440,233$36,297,0004.25%
First Fiduciary Investment Counsel, Inc. 187,633$15,470,0004.10%
GARLAND CAPITAL MANAGEMENT INC 53,555$4,416,0004.02%
Lowell Blake & Associates Inc. 37,219$3,069,0003.94%
PRENTISS SMITH & CO INC 68,027$5,609,0003.89%
View complete list of NOVARTIS A G shareholders